TRLV Trulieve Cannabis Corp.
Stock · NYSE · United States · Healthcare · US89790E1064
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Trulieve Cannabis Corp., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
11.56 USD
+6.06%
52-week range
4.62 – 13.28
Dividend yield—
Market cap2.0B
NowoTrade score
33 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:26. Information, not advice.
Results
Next results
25 Feb 2027
in 109 days · 08:00 · estimate 0.12
Last results
0.09 vs 0.07 estimated
05 Nov 2026 · Beat +28.6%
Beat the estimate
11 of 12
1 missed · 0 in line · 4 beats in a row
Average surprise
+82.9%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 0.12 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 0.07 | 0.09 | +28.6% | Beat |
| 07 Aug 2026 06:00 | 0.03 | 0.11 | +266.7% | Beat |
| 07 May 2026 06:00 | -0.05 | 0.10 | +300.0% | Beat |
| 26 Feb 2026 06:00 | -0.03 | -0.02 | +31.0% | Beat |
| 05 Nov 2025 06:00 | -0.07 | -0.07 | -3.3% | Miss |
| 06 Aug 2025 06:00 | -0.05 | -0.04 | +24.2% | Beat |
| 07 May 2025 06:00 | -0.09 | -0.02 | +77.8% | Beat |
| 27 Feb 2025 06:00 | -0.35 | 0.02 | +105.7% | Beat |
| 05 Nov 2024 06:00 | -0.13 | -0.06 | +55.5% | Beat |
| 06 Aug 2024 07:00 | -0.09 | — | +100.0% | — |
| 09 May 2024 06:00 | -0.11 | -0.05 | +53.1% | Beat |
| 29 Feb 2024 06:00 | -0.13 | -0.12 | +8.4% | Beat |
| 09 Nov 2023 06:00 | -0.15 | -0.08 | +47.4% | Beat |
| 09 Aug 2023 07:00 | -0.18 | -0.08 | +56.5% | Beat |
| 10 May 2023 06:00 | -0.16 | -0.11 | +29.7% | Beat |
| 08 Mar 2023 06:00 | -0.08 | -0.18 | -121.5% | Miss |
| 09 Nov 2022 16:00 | -0.03 | 0.02 | +158.8% | Beat |
| 10 Aug 2022 06:00 | 0.08 | -0.01 | -112.4% | Miss |
| 12 May 2022 06:00 | 0.06 | 0.01 | -84.4% | Miss |
| 30 Mar 2022 10:00 | 0.16 | 0.01 | -93.7% | Miss |
| 15 Nov 2021 06:00 | 0.28 | 0.17 | -39.9% | Miss |
| 12 Aug 2021 07:00 | 0.30 | 0.33 | +9.1% | Beat |
| 13 May 2021 07:00 | 0.31 | 0.27 | -14.6% | Miss |
| 23 Mar 2021 11:00 | 0.24 | 0.33 | +40.0% | Beat |
| 17 Nov 2020 07:00 | 0.21 | 0.04 | -81.0% | Miss |
| 12 Aug 2020 07:00 | 0.12 | 0.06 | -49.3% | Miss |
| 20 May 2020 07:00 | 0.11 | 0.12 | +7.6% | Beat |
| 08 Apr 2020 07:00 | 0.11 | 0.34 | +207.1% | Beat |
| 18 Nov 2019 17:00 | 0.13 | 0.55 | +328.0% | Beat |
| 14 Aug 2019 17:00 | 0.12 | 0.52 | +347.0% | Beat |
| 28 May 2019 19:00 | 0.11 | 0.13 | +20.9% | Beat |
| 10 Apr 2019 19:00 | 0.07 | 0.10 | +49.3% | Beat |
| 19 Nov 2018 07:00 | 0.14 | 0.18 | +28.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.2B | -0.4% | -116.4M | -9.9% | -0.61 | +25.6% | 212.3M |
| 2024 | 1.2B | +5.1% | -155.1M | -13.1% | -0.82 | +70.6% | 123.8M |
| 2023 | 1.1B | -7.3% | -526.8M | -46.7% | -2.79 | -113.0% | 151M |
| 2022 | 1.2B | — | -246.1M | -20.2% | -1.31 | — | -170.7M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 03 Jan 2023 – 06 Jan 2023 | 7.55 | 7.84 | 7.22 | 7.35 | -2.91% | 934,400 | |
| 27 Dec 2022 – 30 Dec 2022 | 7.60 | 7.74 | 6.80 | 7.57 | -0.18% | 2,648,400 | |
| 19 Dec 2022 – 23 Dec 2022 | 8.73 | 8.85 | 6.39 | 7.58 | -14.21% | 4,922,700 | |
| 12 Dec 2022 – 16 Dec 2022 | 10.80 | 11.36 | 8.34 | 8.84 | -21.49% | 2,431,700 | |
| 05 Dec 2022 – 09 Dec 2022 | 14.52 | 16.11 | 10.82 | 11.26 | -22.08% | 3,112,600 | |
| 28 Nov 2022 – 02 Dec 2022 | 12.96 | 14.75 | 12.17 | 14.45 | +10.94% | 1,501,800 | |
| 21 Nov 2022 – 25 Nov 2022 | 12.70 | 13.20 | 11.31 | 13.03 | +2.56% | 876,300 | |
| 14 Nov 2022 – 18 Nov 2022 | 11.12 | 13.00 | 11.02 | 12.70 | +14.62% | 1,653,800 | |
| 07 Nov 2022 – 11 Nov 2022 | 10.95 | 11.82 | 10.43 | 11.08 | +0.64% | 1,859,700 | |
| 31 Oct 2022 – 04 Nov 2022 | 10.85 | 11.91 | 10.42 | 11.01 | +1.94% | 1,184,100 | |
| 24 Oct 2022 – 28 Oct 2022 | 11.75 | 11.75 | 10.26 | 10.80 | -4.09% | 804,800 | |
| 17 Oct 2022 – 21 Oct 2022 | 9.76 | 11.64 | 9.50 | 11.26 | +15.84% | 1,152,900 | |
| 10 Oct 2022 – 14 Oct 2022 | 12.15 | 12.45 | 9.50 | 9.72 | -19.60% | 2,200,900 | |
| 03 Oct 2022 – 07 Oct 2022 | 8.52 | 13.50 | 8.51 | 12.09 | +42.24% | 3,578,300 | |
| 26 Sep 2022 – 30 Sep 2022 | 9.30 | 9.62 | 8.29 | 8.50 | -8.01% | 1,442,600 | |
| 19 Sep 2022 – 23 Sep 2022 | 11.10 | 11.27 | 9.20 | 9.24 | -17.87% | 1,506,000 | |
| 12 Sep 2022 – 16 Sep 2022 | 12.83 | 13.52 | 11.14 | 11.25 | -16.79% | 1,130,800 | |
| 06 Sep 2022 – 09 Sep 2022 | 14.52 | 14.53 | 12.80 | 13.52 | -6.31% | 452,400 | |
| 29 Aug 2022 – 02 Sep 2022 | 13.34 | 15.20 | 13.34 | 14.43 | +0.56% | 810,900 | |
| 22 Aug 2022 – 26 Aug 2022 | 12.35 | 14.45 | 12.01 | 14.35 | +11.76% | 1,899,300 | |
| 15 Aug 2022 – 19 Aug 2022 | 12.91 | 13.30 | 12.26 | 12.84 | -2.36% | 1,096,300 | |
| 08 Aug 2022 – 12 Aug 2022 | 13.94 | 13.94 | 12.67 | 13.15 | +0.23% | 1,281,600 | |
| 01 Aug 2022 – 05 Aug 2022 | 12.50 | 13.63 | 12.43 | 13.12 | +2.42% | 844,400 | |
| 25 Jul 2022 – 29 Jul 2022 | 12.84 | 13.99 | 12.18 | 12.81 | -5.53% | 1,013,900 | |
| 18 Jul 2022 – 22 Jul 2022 | 12.20 | 13.80 | 11.66 | 13.56 | +12.16% | 1,729,500 |
Page 9 of 11
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Trulieve Cannabis Corp. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 06 Nov 2026 02:01
- Trulieve (TRLV) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:45
- Trulieve Cannabis Corp. Reports Third Quarter 2026 Revenue of $230 million (opens in a new tab) Fintel · 05 Nov 2026 15:22
- Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 13:44
- Trulieve Reports Third Quarter 2026 Results (opens in a new tab) 05 Nov 2026 11:15
- Trulieve Cannabis Q3 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $230.000M Beat $218.321M Estimate (opens in a new tab) Benzinga · 05 Nov 2026 07:16
- What Just Happened With Trulieve Cannabis (TRLV) Shares? (opens in a new tab) Simply Wall St. · 03 Nov 2026 03:16
- Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations (opens in a new tab) 02 Nov 2026 14:17
- Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target (opens in a new tab) Benzinga · 02 Nov 2026 13:49
- Trulieve Cannabis Awarded Registrations For Medical Marijuana Dispensaries From U.S. Drug Enforcement Administration (opens in a new tab) Benzinga · 02 Nov 2026 10:24
- Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis (opens in a new tab) Zacks · 12 Oct 2026 12:55
- 3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds (opens in a new tab) Zacks · 09 Oct 2026 13:31
- 2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors (opens in a new tab) Motley Fool · 03 Oct 2026 12:20
- Trulieve Cannabis (TRLV) Falls On Rescheduling Delay, Is It Now A Bargain? (opens in a new tab) Simply Wall St. · 01 Oct 2026 17:09
- Cannabis Stocks Are Slumping. A Procedural DEA Delay Is to Blame. (opens in a new tab) Barrons.com · 30 Sep 2026 18:11
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 10.90 USD
- Market cap
- 2.0B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 0.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 14.2 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 13.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 19.59× | Fair | 14.89× |
| Price / book | 2.88× | Fair | 3.8× |
| Price / sales | 1.82× | Good | 3.19× |
| EV / EBITDA | 7.71× | Good | 12.61× |
| Free cash flow yield | 7.6% | Good | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 60.6% | Good | 58.6% |
| Operating margin | 18.4% | Good | 7.6% |
| Net margin | -41.2% | Weak | 2.7% |
| Return on equity | -45.6% | Weak | 5.7% |
| Return on assets | 3.3% | Fair | 3.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -1% | Weak | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.75× | Good | 0.48× |
| Net debt / EBITDA | 0.89× | Good | 1.6× |
| Interest cover | 2.34× | Weak | 2.65× |
| Current ratio | 5.52× | Good | 2.36× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow TRLV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.